| Product Code: ETC6750079 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Patented Drugs Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Patented Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 China Patented Drugs Market - Industry Life Cycle |
3.4 China Patented Drugs Market - Porter's Five Forces |
3.5 China Patented Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.6 China Patented Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 China Patented Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 China Patented Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in research and development for patented drugs in China |
4.2.2 Growing healthcare infrastructure and access to advanced medical treatments |
4.2.3 Favorable government policies and regulations supporting the development and commercialization of patented drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and patent protection |
4.3.2 Intense competition from generic drug manufacturers |
4.3.3 Challenges in intellectual property rights protection and enforcement in China |
5 China Patented Drugs Market Trends |
6 China Patented Drugs Market, By Types |
6.1 China Patented Drugs Market, By Distribution Channel |
6.1.1 Overview and Analysis |
6.1.2 China Patented Drugs Market Revenues & Volume, By Distribution Channel, 2021- 2031F |
6.1.3 China Patented Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.1.4 China Patented Drugs Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
6.1.5 China Patented Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2 China Patented Drugs Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 China Patented Drugs Market Revenues & Volume, By Solid Drug Product, 2021- 2031F |
6.2.3 China Patented Drugs Market Revenues & Volume, By Liquid Drug Product, 2021- 2031F |
6.2.4 China Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Patented Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 China Patented Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 China Patented Drugs Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 China Patented Drugs Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.5 China Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 China Patented Drugs Market Import-Export Trade Statistics |
7.1 China Patented Drugs Market Export to Major Countries |
7.2 China Patented Drugs Market Imports from Major Countries |
8 China Patented Drugs Market Key Performance Indicators |
8.1 Number of new drug patents filed and approved in China |
8.2 Investment in research and development for patented drugs in the country |
8.3 Number of partnerships and collaborations between local and international pharmaceutical companies for patented drug development |
9 China Patented Drugs Market - Opportunity Assessment |
9.1 China Patented Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.2 China Patented Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 China Patented Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 China Patented Drugs Market - Competitive Landscape |
10.1 China Patented Drugs Market Revenue Share, By Companies, 2024 |
10.2 China Patented Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here